SARS is a newly identified human infection caused by a corona virus unlike any other known human or animal virus in its family. The analysis of epidemiological information obtained from the sites of the outbreaks of SARS is still underway but the overall case fatality ratio is known to approach 11% although the rate among the elderly is much higher. Currently the major challenges for the treatment of SARS are: the source of the SARS virus and mode of transmission are still not well understood; there are problems with diagnostic tools; there is no effective treatment; and there is no vaccine for SARS. The above-mentioned difficulties and challenges have motivated national authorities health workers and scientists to explore the potential of complementary treatment. The results of research on integrated treatment with TCM and Western medicine showed that it is safe and that it also has some potential clinical benefits. Therefore the experts suggested that records of such experience could serve as reference material for treatment of SARS in the future. This publication is intended to share experience in the complementary treatment of SARS patients; share the experience of clinical studies in the field of traditional medicine for treatment of SARS between the physicians and researchers; and to further encourage and promote the quality of research in the filed of traditional medicine.
Mather HG , Pearson NG , Read KLQ , Steed GR , Thorne MG , Jones S , Guerrier CJ , Eraut 2 CD , McHugh PM , Chowdhury NR , Jafary MH , Wallace TJ : Acute myocardial infarction : Home and hospital treatment .
Comprehensive book that suggests ways to improve the efficiency of clinical trials and the development of interventions in the neurosciences.
50 Studies Every Pediatrician Should Know presents summaries of key studies that have shaped the current clinical practice of pediatrics. Numerous subspecialties are covered, including cardiology and neonatology.
The completely updated and expanded 2013 guide includes: Input from an Expert Advisory Panel including distinguished international GCP experts who have assured that the book contains the most current and up-to-date information on global GCP ...
The method only requires information from individuals who have experienced the event of interest, and automatically controls for multiplicative time-invariant confounders, even when these are unmeasured or unknown.
Brownlee KA : Statistical theory and methodology in science and engineering , New York , 1965 , John Wiley & Sons . 21. ... DeSilva RA , Hennekcns CH , Lown B , Casscells W : Lignocaine prophylaxis in acute myocardial infarction : an ...
Name Gradishar , William J ( IL ) Grado , Gordon L ( AZ ) Graham , Mark ( NC ) Graham , Michael L ( AZ ) Graham - Pole ... Clarence S ( CA ) Greenson , Joel K ( MI ) Greenway , Hubert T ( CA ) Greer , Benjamin ( WA ) Greer , John P ...
J. Mark Elwood. Q6.10 A screening test applied to 1000 subjects identified 100 of them as positive. ... Brenner H, Arndt V, Stegmaier C, Ziegler H, Rothenbacher D. Is Helicobacter pylori infection a necessary condition for noncardia ...
The idea for this manual came from Pfizer in the US, which provided the Clinical Trials Centre at The University of Hong Kong, Hong Kong SAR, PR China with a nonbinding grant for its development.
A comprehensive and practical guide covering the multidisciplinary aspects of clinical drug research.